Motilal Oswal Sees Aster DM EBITDA Rising 25% CAGR Through FY28, Sets Rs 910 Target
Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and a target price of Rs 910, arguing that merger synergies, capacity expansion and improving operating metrics should drive a sustained earnings re-rating. The brokerage expects revenue, EBITDA and PAT to compound at 19.5%, 25% and 33%, respectively, through FY28, placing the hospital chain among the more attractive growth stories in Indiaโs healthcare services space.
